Celularity Inc.
CELUNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for CELU. That does not mean none is planned.
Get an email about CELU's next catalysts
Track Celularity (CELU) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
PDA-002
Diabetic Nephropathies
CYNK-001
Coronavirus
Human Placenta-Derived Cells PDA001 Intravenous Infusion
Crohn's Disease
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
PDA-002 | Phase 2 | Diabetic Nephropathies | - | - |
CYNK-001 | Phase 2 | Coronavirus | - | - |
Human Placenta-Derived Cells PDA001 Intravenous Infusion | Phase 2 | Crohn's Disease | - | - |
Frequently asked questions
What is in Celularity Inc.'s drug pipeline?β
CatalystAlert tracks 3 drug candidates in Celularity Inc.'s (CELU) pipeline across Phase 2. Its lead program is CYNK-001 (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is Celularity Inc.'s next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for Celularity Inc. (CELU) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track CELU biotech catalysts?β
Add CELU to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Celularity Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
